-
*|MC_PREVIEW_TEXT|* | | | | Antibiotics Resistance
23 March 2023
WHO considers antibiotic resistance to be one of the biggest threats to global health, food security, and development today. Antibiotic resistance can affect anyone, of any age, in any country and occurs naturally, but misuse of antibiotics in humans and animals is accelerating the process.
Join us for a 90-minute fireside chat with Bill Burns, former CEO of Roche Pharma, to speak about the challenges of antibiotic resistance and potential mitigation strategies. | | William M. Burns
William M. Burns spent 28 years working for Roche Pharmaceuticals culminating in his tenure as CEO from 2001 to 2009. He has served as a director and trustee for many organizations, including Roche, Genentech, the Wellcome Trust Ltd., and the Institute of Cancer Research London. He holds a bachelor’s degree in economics from the University of Strathclyde, Glasgow. | | Eva Jenisch, MBA ‘95J
Eva Jenisch founded Jenisch Consulting with a focus on Business Process Improvement and Lean Management after working over 20 years with Roche Pharma technical operations. Eva holds an MBA ‘95J from Insead and is a Swiss Healthcare Club leadership team member. | | Programme
17:00 Welcome
17:30 Fireside chat, incl. Q&A
19.00 Apéro Riche
Key Facts
When: Thursday 23 March 2023 17:00
Where: Biozentrum, University of Basel, Auditorium U1.111, Spitalstrasse 41, CH-4056 Basel
Tickets: CHF 30 NAA Members (paid-up) // CHF 40 Alumni non-members and guests
INSEAD Alumni Association Switzerland
Eva Jenisch, MBA’95J, Swiss Healthcare Club leadership team member
Aleksandar Ruzicic, MBA’97J, Swiss Healthcare Club President | | | | | | |
-
|
|
